| Mr Kevin Scott Langley, APRN-CNP | |
|
1921 Stonecipher Blvd, Ada, OK 74820 | |
| (580) 421-4570 | |
| Not Available |
| Full Name | Mr Kevin Scott Langley |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1921 Stonecipher Blvd, Ada, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851644413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 66986 (Oklahoma) | Primary |
| 363LF0000X | Nurse Practitioner - Family | 829380 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chickasaw Nation Medical Center | Ada, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chickasaw Nation Division Of Health | 8426957523 | 209 |
News Archive
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
Colorectal cancer is the second leading cause of cancer death in the country. While the rates of colorectal cancer among patients older than 50 years old has decreased in recent years due to screening, it has increased by 22 percent among those under the age of 50, which could place a burden on the health care system over the next decade.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
Professionalization in any field requires long-term experience and training. In the past decades, studies have demonstrated that the professionalization of athletes and artists create differences in the behavior of the brain while carrying out activities related to their area of expertise.
› Verified 3 days ago
| Entity Name | Chickasaw Nation Division Of Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255364923 PECOS PAC ID: 8426957523 Enrollment ID: O20040108000364 |
News Archive
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
Colorectal cancer is the second leading cause of cancer death in the country. While the rates of colorectal cancer among patients older than 50 years old has decreased in recent years due to screening, it has increased by 22 percent among those under the age of 50, which could place a burden on the health care system over the next decade.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
Professionalization in any field requires long-term experience and training. In the past decades, studies have demonstrated that the professionalization of athletes and artists create differences in the behavior of the brain while carrying out activities related to their area of expertise.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kevin Scott Langley, APRN-CNP 1921 Stonecipher Blvd, Ada, OK 74820 Ph: (580) 421-4570 | Mr Kevin Scott Langley, APRN-CNP 1921 Stonecipher Blvd, Ada, OK 74820 Ph: (580) 421-4570 |
News Archive
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
Colorectal cancer is the second leading cause of cancer death in the country. While the rates of colorectal cancer among patients older than 50 years old has decreased in recent years due to screening, it has increased by 22 percent among those under the age of 50, which could place a burden on the health care system over the next decade.
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
Professionalization in any field requires long-term experience and training. In the past decades, studies have demonstrated that the professionalization of athletes and artists create differences in the behavior of the brain while carrying out activities related to their area of expertise.
› Verified 3 days ago
Akilah Talibah Dunn, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Blvd., Ada, OK 74820 Phone: 580-436-3980 | |
Mrs. Linda Louise Spooner, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2330 Arlington St, Ada, OK 74820 Phone: 580-332-2011 Fax: 580-332-9537 | |
Dr. Tosha Lucille Wilson, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 709 Better Now Plz, Ada, OK 74820 Phone: 580-310-9989 | |
Qiong Mu Ross, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 905 Colony Dr, Ada, OK 74820 Phone: 580-436-5111 Fax: 580-436-1159 | |
Robin M Losee, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-421-4570 | |
Michelle Ann Cole, APRN FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 709 Better Now Plz, Ada, OK 74820 Phone: 580-310-9899 Fax: 580-310-9818 | |
Shari M Rhodes, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 Arlington St Ste F, Ada, OK 74820 Phone: 580-279-1788 |